Cargando…
In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain
BACKGROUND: Neuraminidase (NA) is a prominent surface antigen of Influenza viruses, which helps in release of viruses from the host cells after replication. Anti influenza drugs such as Oseltamivir target a highly conserved active site of NA, which comprises of 8 functional residues (R118, D151, R15...
Autores principales: | Hussain Basha, Syed, Prasad, R Nalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369820/ https://www.ncbi.nlm.nih.gov/pubmed/22340192 http://dx.doi.org/10.1186/1756-0500-5-105 |
Ejemplares similares
-
Miscellaneous Antiviral Agents (Interferons, Imiquimod, Pleconaril)
por: Dolin, Raphael
Publicado: (2015) -
In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015) -
In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
por: Ganguli, Sayak, et al.
Publicado: (2010) -
Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus
por: Quiliano, MiguelMiguel, et al.
Publicado: (2013) -
Retraction: In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
por: Ganguli, Sayak, et al.
Publicado: (2010)